# FDA Inspection 1045145 - Joel Schlessinger, M.D. - January 18, 2018

Source: https://www.keypedia.com/records/fda_inspections/joel-schlessinger-md/a2d89004-6b9c-49d0-b9b6-b1ea3c10caf9
Source feed: FDA_Inspections

> FDA Inspection 1045145 for Joel Schlessinger, M.D. on January 18, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1045145
- Company Name: Joel Schlessinger, M.D.
- Inspection Date: 2018-01-18
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1155209 - 2021-10-08](https://www.keypedia.com/records/fda_inspections/joel-schlessinger-md/92715034-241c-4464-99f6-5a763f5115d1)
- [FDA Inspection 1112518 - 2019-12-12](https://www.keypedia.com/records/fda_inspections/joel-schlessinger-md/19e122bb-796c-4515-aaef-661b1f356468)
- [FDA Inspection 998471 - 2017-01-18](https://www.keypedia.com/records/fda_inspections/joel-schlessinger-md/970e26e1-4ae3-408e-8ed1-0ee006c88c84)
- [FDA Inspection 545398 - 2008-10-23](https://www.keypedia.com/records/fda_inspections/joel-schlessinger-md/6d980857-612e-49f3-ac19-6876069bbf30)

Company: https://www.keypedia.com/companies/joel-schlessinger-md/43825d93-b0cc-4998-a844-76df360610ee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c